The FDA has authorized expanded use of some noninvasive patient monitoring devices to reduce contact between healthcare workers and patients.
Category: FDA Approvals
The FDA has approved the Fluzone High-Dose Quadrivalent (Influenza Vaccine) for adults 65 years of age and older. The vaccine will be available for fall 2020.Read More
Royal Philips has received FDA 510(k) approval for the EarlyVue VS30, a new vital signs monitor in the US.Read More
The FDA has granted Ofev (nintedanib) a breakthrough therapy designation for chronic fibrosing interstitial lung disease, according to Boehringer Ingelheim.Read More
Monaghan Medical Corp has introduced a new intermediate-sized ComfortSeal mask for its Aerochamber valved holding chamber device.Read More